Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes

Area of Science:

• Immunology
• Endocrinology
• Metabolic disease research

Background:

• Pancreatic islets regulate glucose homeostasis via insulin secretion from beta cells.
• Obesity-induced type 2 diabetes (T2D) leads to beta cell dysfunction and inadequate insulin secretion.
• T2D is characterized by chronic low-grade inflammation in metabolic organs, including pancreatic islets.

Purpose of the Study:

• To review current knowledge on islet inflammation and macrophage roles in humans and rodents.
• To discuss cellular and molecular mechanisms of islet remodeling and beta cell function in obesity and T2D.
• To highlight the unclear phenotypes and functions of islet macrophages in health and T2D.

Main Methods:

• Literature review of existing studies on pancreatic islet macrophages.
• Synthesis of findings from human and rodent models of T2D.
• Analysis of cellular and molecular mechanisms impacting islet function.

Main Results:

• Islet macrophages are implicated in regulating islet homeostasis.
• Beta cell dysfunction in T2D is linked to islet inflammation.
• The precise roles and phenotypes of islet macrophages in T2D require further elucidation.

Conclusions:

• Islet macrophages are critical players in the inflammatory processes associated with T2D.
• Further research into islet macrophage biology is essential for understanding and treating T2D.
• Targeting islet inflammation and macrophages may offer therapeutic strategies for T2D.